Evidence map›Paper›PMID 42240381›Full record

ArticleAntimicrobial agents and chemotherapy2026

Does early letermovir initiation delay engraftment?

Léna Royston, Catia Vieira Gomes, Ming Zou, Christian Van Delden, Laurent Kaiser, Yves Chalandon, Stavroula Masouridi-Levrat, Dionysios Neofytos

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Léna RoystonDivision of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland.ORCID 0000-0003-2367-7682
Catia Vieira GomesDivision of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland.
Ming ZouUniversity Hospital Basel, Basel, Switzerland.ORCID 0000-0002-8567-2134
Christian Van DeldenDivision of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland.
Laurent KaiserDivision of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland.
Yves ChalandonDivision of Hematology, Bone Marrow Transplant Unit, University Hospital of Geneva, Geneva, Switzerland.
Stavroula Masouridi-LevratDivision of Hematology, Bone Marrow Transplant Unit, University Hospital of Geneva, Geneva, Switzerland.
Dionysios NeofytosDivision of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland.ORCID 0000-0001-6970-2869

Funding

Swiss National Science Foundation PZ00P3_223662
6 · The paper itself

Abstract

Although letermovir prophylaxis has drastically reduced cytomegalovirus (CMV) infections in allogeneic hematopoietic cell transplantation recipients (allo-HCTR), the broader impact of letermovir prophylaxis remains unclear. We retrospectively analyzed hematological outcomes in CMV-seropositive allo-HCTR (R+) from the pre- and letermovir periods. Among 314 consecutive allo-HCTR+, engraftment was significantly delayed in allo-HCTR+ in the letermovir period, even after removing potential confounders, and despite improved survival. Similar trends were found after reviewing the literature, and this observation should raise vigilance.

Indexed as

AcetatesAntiviral AgentsCytomegalovirus InfectionsHematopoietic Stem Cell TransplantationQuinazolinesCytomegalovirusFemaleHumansRetrospective StudiesTransplantation, HomologousAcetatesAntiviral AgentsletermovirQuinazolinesantiviralcmvcytomegalovirusengraftmenthematopoietic cell transplantationletermovirside effect

Identifiers

PMID42240381
PMCPMC13321813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.